| Biotechnology Industry | Healthcare Sector | Mr. Shuang Liu CEO | XSHE Exchange | CNE100002QC3 ISIN |
| CN Country | 1,272 Employees | - Last Dividend | 22 Aug 2018 Last Split | - IPO Date |
Tiansheng Pharmaceutical Group Co., Ltd., established in 2001 and headquartered in Chongqing, China, operates in the pharmaceutical sector with a broad engagement in manufacturing and circulation activities. The company has developed a robust portfolio, delivering a wide range of healthcare solutions across various medical fields. Its commitment to health and wellbeing is reflected in its extensive product offerings, catering to multiple therapeutic areas and patient needs.
Tiansheng Pharmaceutical Group Co., Ltd. offers a diversified selection of products and services across multiple healthcare categories, including: